The largest holder of Intuitive Surgical stock is Vanguard Capital Management LLC, with 23.1 million shares (6.55% of the company), worth about $8.72 billion as of September 25, 2026. The 10 largest holders together own 34.3%.
In Q2 2026, 2,377 institutional holdings reports listed shares worth $123.00 billion.
Insiders reported 100 transactions in the last two years: 33 sales worth $88.56 million and no purchases. The newest one on file is from May 11, 2026 (Loeb Gary, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 11, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 23.1 million | 6.55% | $8.7B |
| BlackRock Advisors LLC | 21.7 million | 6.13% | $8.2B |
| State Street Corporation | 16.1 million | 4.55% | $6.1B |
| Invesco Advisers, Inc. | 11.8 million | 3.35% | $4.5B |
| T. Rowe Price International Ltd. | 11.3 million | 3.19% | $4.2B |
| Geode Capital Management LLC | 8.5 million | 2.42% | $3.2B |
| Capital Research & Management Co. (World Investors) | 7.7 million | 2.19% | $2.9B |
| BlackRock Life Ltd. | 7.3 million | 2.06% | $2.7B |
| Vanguard Portfolio Management LLC | 7.2 million | 2.05% | $2.7B |
| Eaton Vance Management | 6.6 million | 1.86% | $2.5B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,377 | – | $123.0B |
| Q1 2026 | 2,433 | 301.0 million | $139.0B |
| Q4 2025 | 2,535 | 311.0 million | $174.0B |
| Q3 2025 | 2,246 | 297.0 million | $132.0B |
| Q2 2025 | 2,389 | 309.0 million | $166.0B |
| Q1 2025 | 2,307 | 304.0 million | $151.0B |
| Q4 2024 | 2,240 | 305.0 million | $159.0B |
| Q3 2024 | 2,064 | 313.0 million | $153.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Loeb Gary | May 11, 2026 | Officer | Sale at price 446.95 per share. | $178,780 |
| Chew Lewis | Apr 30, 2026 | Director | -- | – |
| Johnson Amal M | Apr 30, 2026 | Director | -- | – |
| Beery Joseph C | Apr 30, 2026 | Director | -- | – |
| Nachtsheim Jami Dover K | Apr 30, 2026 | Director | -- | – |
| Leonard Keith R Jr | Apr 30, 2026 | Director | -- | – |
| Barratt Craig H | Apr 30, 2026 | Director | -- | – |
| Reed Monica P | Apr 30, 2026 | Director | -- | – |
| Ladd Amy L | Apr 30, 2026 | Director | -- | – |
| Kolli Sreelakshmi | Apr 30, 2026 | Director | -- | – |
| Ladd Amy L | Apr 29, 2026 | Director | Sale at price 463.50 - 473.46 per share. | $291,886 |
| Curet Myriam J | Mar 10, 2026 | Officer | Conversion of Exercise of derivative security at price 229.39 per share. | $24,086 |
Newest 12 of 100 insider transactions in the last two years.
Vanguard Capital Management LLC, with 6.55% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.13%) and State Street Corporation (4.55%).
2,377 institutional holdings reports listed Intuitive Surgical shares in Q2 2026 worth $123.00 billion.
In the last two years insiders reported 33 sales and no purchases (100 transactions in all); the newest on file is from May 11, 2026.